Dopaminergic Drugs Flashcards
Carbidopa
Given with Levodopa
Turns off conversion of DA outside the brain
MAO-B inhibitors
Decreases the metabolism of DA, works in the brain. Blocks the breakdown of levodopa and DA, specific for DA
Insomnia, dyskinesia, hypotension
Doesn’t work well on its own- paired with levodopa
*hypertensive Crisis, serotonin syndrome
COMT’s
Inhibitor, decreases the metabolism of DA and Levodopa, works in the brain- augments ldopa available
Doesn’t work on own- paired with levodopa
Delayed Onset diarrhea (after 2wk)
Levodopa
Transpired to the CNS and converted to DA and bind to D1 and D2 receptors
Given with carbidopa
Used at a later stage when symptoms are high, choice after using DRA
Dyskinesia in 80% of patients
Wearing off
N/V, orthostatic hypotension
Psychosis, sedation, ICD
Melanoma risk
Dopamine receptor agonists
Used with young patients at early stage (first choice)
Act like DA but don’t get converted-activate receptors to produce response
Less effective on movement disorders
Not as effective as levodopa
Low dyskinesia
*hallucinations, sleepiness, orthostasis (older patients)
N/V, syncope
Pretreat with antiemetic
- avoid 5-HT3 agonists or promethazine
Bromocriptine
DRA
Ergot derivative
Cabergoline
DRA
Ergot derivative
Pramipexole
DRA
Non-ergot derivative
Ropinrole (requip)
DRA
Non- ergot derivative
Apomorphine
DRA
Non-ergo derivative
Amantadine
Other DA drug
Smooths out effects of levodopa ( less dyskinesia)
Elimination very sensitive to renal function
Began as antiviral drug
- confusion, dizzy, dry mouth, hallucinations
- livedo reticularis: rash on lower extremity
Anti cholinergic Agents
- Benztropine
- Triexyphenidyl
Other DA drug
Block acetylcholine at muscarnic receptors
Effective on tremors and rigidity
Corrects imbalance of DA as receptors die off
- turns off other functions: peripheral anti muscarnic effects, drowsiness confusion delusions memory problems
Levodopa
Carbidopa
MAO-B inhibitors
COMT
Dopamine Agonists
Bromocriptine Cabergoline Ropinrole Apomorphine Pramipexole
Dopamine Receptor Agonists